Literature DB >> 26054833

Structural evidences for a secondary gold binding site in the hydrophobic box of lysozyme.

Giarita Ferraro1, Lara Massai, Luigi Messori, Maria Agostina Cinellu, Antonello Merlino.   

Abstract

A new crystal structure is reported here for the adduct formed in the reaction between NH4 [Au(Sac)2], AuSac2, a cytotoxic homoleptic gold(I) complex with the saccharinate ligand, and the model protein hen egg white lysozyme. To produce this adduct, AuSac2 breaks down and releases both saccharinate ligands. The resulting Au(I) ions bind the protein to ND1 and NE2 atoms of His15 but also to SD atom of the zero-solvent accessible Met105 side chain, which is located in the protein hydrophobic box. The unexpected existence of this secondary gold(I) binding site is confirmed by spectroscopic and spectrometric measurements in solution.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26054833     DOI: 10.1007/s10534-015-9863-7

Source DB:  PubMed          Journal:  Biometals        ISSN: 0966-0844            Impact factor:   2.949


  3 in total

1.  Auranofin, Et3PAuCl, and Et3PAuI Are Highly Cytotoxic on Colorectal Cancer Cells: A Chemical and Biological Study.

Authors:  Tiziano Marzo; Damiano Cirri; Chiara Gabbiani; Tania Gamberi; Francesca Magherini; Alessandro Pratesi; Annalisa Guerri; Tarita Biver; Francesca Binacchi; Matteo Stefanini; Annarosa Arcangeli; Luigi Messori
Journal:  ACS Med Chem Lett       Date:  2017-09-06       Impact factor: 4.345

Review 2.  Breast Cancer Treatment: The Case of Gold(I)-Based Compounds as a Promising Class of Bioactive Molecules.

Authors:  Rossana Galassi; Lorenzo Luciani; Junbiao Wang; Silvia Vincenzetti; Lishan Cui; Augusto Amici; Stefania Pucciarelli; Cristina Marchini
Journal:  Biomolecules       Date:  2022-01-05

Review 3.  Computational Studies of Au(I) and Au(III) Anticancer MetalLodrugs: A Survey.

Authors:  Iogann Tolbatov; Alessandro Marrone; Cecilia Coletti; Nazzareno Re
Journal:  Molecules       Date:  2021-12-15       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.